Thota Kanishka Rao, Amity University Kolkata Emerged in 2019, and spread rapidly, the Coronavirus Disease 2019 (COVID-19) impacted economies worldwide, overwhelming health-care systems, as it infected millions causing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To respond, a worldwide effort has been initiated to develop vaccines and therapeutic agents. For COVID-19 vaccine development, the trimeric […]
Prama Ghosh, Amity University Kolkata After the recovery of President Donald Trump from Covid-19 using a similar therapy as of the antibody medicine from AstraZeneca Plc, the company has started its late-stage trials for the same against COVID-19. The medicine will undergo two trials on more than 60000 people starting soon. Astra has also planned […]
Sayak Banerjee, Amity University Kolkata Many a time, a heart transplant is the only hope of survival for patients with any cardiac problems when every other surgery fails. For this, they have to wait for too long. Cardiac xenotransplantation has been a target of scientists globally for years, and in one year, pig hearts might […]
Aishila Kar, Amity University Kolkata ICMR officials said on Tuesday that The Drugs Controller General of India has given authorization for conducting Phase-1 human clinical trial for an “antisera” that was developed by injecting inactivated SARS-CoV-2 in horses and can be a treatment for COVID-19. The Indian Council of Medical Research (ICMR) in alliance with a Hyderabad-based vaccine maker […]
Devyani Goswami, Amity University Kolkata It is about a year now that the SARS-CoV-2 has disturbed and changed the daily lifestyle of people all over the world. A vaccine against this virus is what we are hoping for, but that too comes with a drawback that it won’t be able to provide a long-term immunity […]
Ayooshi Mitra, Amity University Kolkata To avert the spread of the pandemic of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), a successful vaccine is needed. In an examination directed recently, safety, tolerability, and neutralizer reaction information from an on-going placebo-controlled treatment observer-blinded phase 1/2 coronavirus disease 2019 (COVID-19) vaccine trial BNT162b1, a lipid nanoparticle (LNP) nucleoside-modified […]
Devyani Goswami, Amity University Kolkata Breast cancer has become one of the common diseases affecting both men and women worldwide, though most common in women as of yet. There are multifactorial reasons for the formation of breast cancer, depending on the type of breast cancer. A common trait observed in all cancer patients is an […]
Prama Ghosh, Amity University Kolkata Severity and death from Coronavirus disease 2019 (Covid-19) are associated with the older population; testing such vaccine candidates is important to prevent infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A phase 1, open-label trial with an escalated dose of messenger RNA vaccine, mRNA-1273, which encodes the stabilized prefusion […]
–PRIYANKA CHAKRABORTY, AMITY UNIVERSITY KOLKATA The foundation for the quest in vaccine discovery lies in antibodies and its immune response. Immunoglobulins (minute proteins) are the sole defenders against invading pathogens. Therefore, the detailed study of the immune system is a fascination around the globe. Recently, Dr. Josef Penninger’s group at IMBA and UBC were amazed […]
